These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options. Williams-Gray CH; Foltynie T; Lewis SJ; Barker RA CNS Drugs; 2006; 20(6):477-505. PubMed ID: 16734499 [TBL] [Abstract][Full Text] [Related]
9. Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease. Solla P; Cannas A; Ibba FC; Loi F; Corona M; Orofino G; Marrosu MG; Marrosu F J Neurol Sci; 2012 Dec; 323(1-2):33-9. PubMed ID: 22935408 [TBL] [Abstract][Full Text] [Related]
12. A 12-year population-based study of psychosis in Parkinson disease. Forsaa EB; Larsen JP; Wentzel-Larsen T; Goetz CG; Stebbins GT; Aarsland D; Alves G Arch Neurol; 2010 Aug; 67(8):996-1001. PubMed ID: 20697051 [TBL] [Abstract][Full Text] [Related]
13. Subthalamic nucleus stimulation for Parkinson disease with severe medication-induced hallucinations or delusions. Umemura A; Oka Y; Okita K; Matsukawa N; Yamada K J Neurosurg; 2011 Jun; 114(6):1701-5. PubMed ID: 21375379 [TBL] [Abstract][Full Text] [Related]
14. Psychosis in nursing home patients with Parkinson's disease. Kang GA; Bronstein JM J Am Med Dir Assoc; 2004; 5(3):167-73. PubMed ID: 15115577 [TBL] [Abstract][Full Text] [Related]
15. Mirtazapine improves visual hallucinations in Parkinson's disease: a case report. Tagai K; Nagata T; Shinagawa S; Tsuno N; Ozone M; Nakayama K Psychogeriatrics; 2013 Jun; 13(2):103-7. PubMed ID: 23909968 [TBL] [Abstract][Full Text] [Related]